Cumulative clinical pregnancy rates after COH and IUI in subfertile couples

Gynecological Endocrinology

Volumn 26, Issue 7, 2010, Pages 500-504

  Farhi, Jacob ^a,b   Orvieto, Raoul ^c  

^a Fertility Clinics   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Age; Coh; Cumulative pregnancy rate; Infertility; Iui

Indexed keywords

ADULT; ARTICLE; FEMALE; HUMAN; INTRAUTERINE INSEMINATION; MATERNAL AGE; OVARY HYPERSTIMULATION; PRACTICE GUIDELINE; PREGNANCY RATE; PRIORITY JOURNAL; SUBFERTILITY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; FEMALE; HUMANS; INFERTILITY, FEMALE; INFERTILITY, MALE; INSEMINATION, ARTIFICIAL; MALE; MIDDLE AGED; OVULATION INDUCTION; PREGNANCY; PREGNANCY RATE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 77953630101     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590903367036     Document Type: Article

References (23)

1. Hughes EG. The effectiveness of ovulation induction and intrauterine insemination in the treatment of persistent infertility: a meta-analysis. Hum Reprod 1997;12:1865-1872.
2. van Rumste MME, Custers IM, van der Veen F, van Wely M, Evers JLH, Mol BWJ. The influence of the number of follicles on pregnancy rates in intrauterine insemination with ovarian stimulation: a meta-analysis. Hum Reprod Update 2008;14: 563-570.
3. Guzick DS, Carson SA, Coutifaris C, Overstreet JW, Factor- Litvak P, Steinkampf MP, Hill JA, Mastroianni L, Buster JE, Nakajima ST, Vogel DL, Canfield RE. Efficacy of superovulation and intrauterine insemination in the treatment of infertility. National Cooperative Reproductive Medicine Network. N Engl J Med 1999;340:177-183.
4. Penzias AS. Improving results with assisted reproductive technologies: individualized patient-tailored strategies for ovulation induction. Reprod Biomed Online 2004;9:43-46.
5. Cantineau AE, Cohlen BJ, Heineman MJ. Ovarian stimulation protocols (anti-oestrogens, gonadotrophins with and without GnRH agonists/antagonists) for intrauterine insemination (IUI) in women with subfertility. Cochrane Database Syst Rev 2007;18:CD005356.
6. Campana A, Sakkas D, Stalberg A, Bianchi PG, Comte I, Pache T, Walker D. Intrauterine insemination: evaluation of the results according to the woman's age, sperm quality, total sperm count per insemination and life table analysis. Hum Reprod 1996;11:732-736.
7. Sahakyan M, Harlow BL, Hornstein MD. Influence of age, diagnosis, and cycle number on pregnancy rates with gonadotropin-induced controlled ovarian hyperstimulation and intrauterine insemination. Fertil Steril 1999;72:500-504.
8. Plosker SM, Jacobson W, Amato P. Predicting and optimizing success in an intra-uterine insemination programme. Hum Reprod 1994;9:2014-2021.
9. Brzechffa PR, Buyalos RP. Female and male partner age and menotropin requirements influence pregnancy rates with human menopausal gonadotropin in combination with intrauterine insemination. Hum Reprod 1997;12:29-33.
10. Van der Westerlaken LA, Naaktgeboren N, Helmerhorst FM. Evaluation of pregnancy rates after intrauterine insemination according to indication, age, and sperm parameters. J Assist Reprod Genet 1998;15:359-364.
11. Nuojua-Huttunen S, Tomas C, Bloigu R, Tuomivaara L, Martikainen H. Intrauterine insemination treatment in subfertility: an analysis of factors affecting outcome. Hum Reprod 1999;14:698-703.
12. Steures P, van der Steeg JW; for CECERM members. Prediction of an ongoing pregnancy after intrauterine insemination. Fertil Steril 2004;82:45-51.
13. Duran H, Morshedi M, Kruger T, Oehninger S. Intrauterine insemination: a systematic review on determinants of success. Hum Reprod Update 2002;8:373-384.
14. Speroff L, Fritz MA. Clinical gynecologic endocrinology and infertility, 7th ed. Baltimore, MD: Lippincott Williams & Wilkins; 2004.
15. Khalil MR, Rasmussen PE, Erb K, Laursen SB, Rex S, Westergaard LG. Intrauterine insemination with donor semen. An evaluation of prognostic factors based on a review of 1131 cycles. Acta Obstet Gynecol Scand 2001;80: 342-348. (Pubitemid 32260685)
16. Papageorgiou TC, Guibert J, Savale M, Goffinet F, Fournier C, Franc MO, Janssens Y, Zorn JR. Low dose recombinant FSH treatment may reducemultiple gestations caused by controlled ovarian hyperstimulation and intrauterine insemination. Br J Obstet Gynaecol 2004;111:1277-1282.
17. WHO laboratory manual for the examination of human semen and sperm-cervical mucus interaction, 4th ed. Cambridge University Press; 1999.
18. Farhi J, Ben-Haroush A, Lande Y, Fisch B. Role of treatment with ovarian stimulation and intrauterine insemination in women with unilateral tubal occlusion diagnosed by hysterosalpingography. Fertil Steril 2007;88:396-400.
19. American Society for Reproductive Medicine, Society for Assisted Reproductive Technology. 2005 Assisted reproductive technology success rates: national summary and fertility clinic reports. Atlanta: Centers for Disease Control and Prevention; 2007.
20. Yang JH, Wu MY, Chao KH, Chen SU, Ho HN, Yang YS. Controlled ovarian hyperstimulation and intrauterine insemination in subfertility - how many treatment cycles are sufficient? J Reprod Med 1998;473:903-908.
21. Harris ID, Missmer SA, Hornstein MD. Poor success of gonadotropin-induced controlled ovarian hyperstimulation and intrauterine insemination for older women. Fertil Steril in press.
22. Collins JA, Crosignani PG. Unexplained infertility: a review of diagnosis, prognosis, treatment efficacy and management. Int J Obstet Gynecol 1992;39:267-275.
23. Aboulghar M, Mansour R, Serour G, Abdrazek A, Amin Y, Rhodes C. Controlled ovarian hyperstimulation and intrauterine insemination for treatment of unexplained infertility should be limited to a maximum of three trials. Fertil Steril 2001;75:88-91.